We are live on
!
Find out more
Mariner Portfolio holdings
AUM
$85.7B
1-Year Est. Return
24.21%
This Fund
S&P 500
This Quarter
Est. Return
-0.55%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$19.2B
AUM Growth
+$3.04B
(+19%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
16.94%
Top 10 Holdings %
Top 10 Hldgs %
24.01%
Holding
1,030
New
119
Increased
631
Reduced
215
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$312M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$202M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$182M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$146M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$99.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$27.6M |
| 2 |
Elanco Animal Health
ELAN
|
+$27.1M |
| 3 |
Air Products & Chemicals
APD
|
+$26.8M |
| 4 |
Accenture
ACN
|
+$19M |
| 5 |
Micron Technology
MU
|
+$17.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.42% |
| 2 | Healthcare | 6.73% |
| 3 | Financials | 6.54% |
| 4 | Consumer Discretionary | 4.95% |
| 5 | Industrials | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $2.08M | 0.01% |
66,609
+23,193
| +53% | +$725K |
|
527
International Flavors & Fragrances
IFF
$19.4B
| $2.08M | 0.01% |
15,546
+1,182
| +8% | +$174K |
|
528
10x Genomics
TXG
$5.87B
| $2.07M | 0.01% |
14,243
-924
| -6% | -$159K |
|
529
iShares US Medical Devices ETF
IHI
$3.02B
| $2.07M | 0.01% |
+32,999
| New | +$2.11M |
|
530
eBay
EBAY
$48.6B
| $2.04M | 0.01% |
29,307
+722
| +3% | +$51.7K |
|
531
RPM International
RPM
$13.7B
| $2.03M | 0.01% |
26,180
-1,518
| -5% | -$128K |
|
532
Brown-Forman Class B
BF.B
$12B
| $2.03M | 0.01% |
30,260
-4,036
| -12% | -$286K |
|
533
Vanguard Russell 2000 ETF
VTWO
$17.3B
| $2.02M | 0.01% |
22,906
+4,149
| +22% | +$371K |
|
534
Aflac
AFL
$63.9B
| $2.02M | 0.01% |
38,748
+2,513
| +7% | +$137K |
|
535
iShares US Technology ETF
IYW
$23.7B
| $2.01M | 0.01% |
19,862
+10
| +0.1% | +$1.04K |
|
536
HDFC Bank
HDB
$119B
| $2.01M | 0.01% |
55,002
+11,746
| +27% | +$436K |
|
537
Vanguard Industrials ETF
VIS
$8.23B
| $2.01M | 0.01% |
10,700
+100
| +0.9% | +$19.6K |
|
538
Intellia Therapeutics
NTLA
$1.5B
| $2M | 0.01% |
14,947
-38
| -0.3% | -$5.75K |
|
539
GSK
GSK
$103B
| $2M | 0.01% |
41,759
+6,381
| +18% | +$321K |
|
540
Western Midstream Partners
WES
$19.6B
| $1.99M | 0.01% |
94,857
-1,104
| -1% | -$22K |
|
|
RDS.B
541
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.99M | 0.01% |
44,917
+1,704
| +4% | +$67.5K |
|
542
Stanley Black & Decker
SWK
$14.2B
| $1.97M | 0.01% |
11,260
+182
| +2% | +$35.5K |
|
543
Civista Bancshares
CIVB
$594M
| $1.97M | 0.01% |
84,593
+321
| +0.4% | +$7.37K |
|
544
STAAR Surgical
STAA
$1.16B
| $1.97M | 0.01% |
+15,290
| New | +$2.14M |
|
545
M/I Homes
MHO
$3.83B
| $1.96M | 0.01% |
33,911
+22
| +0.1% | +$1.35K |
|
546
Entegris
ENTG
$19.7B
| $1.96M | 0.01% |
15,541
+317
| +2% | +$38.2K |
|
547
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
| $1.96M | 0.01% |
38,321
+10,994
| +40% | +$586K |
|
548
Targa Resources
TRGP
$60.4B
| $1.94M | 0.01% |
39,478
+2,488
| +7% | +$110K |
|
|
EVBG
549
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.92M | 0.01% |
12,718
-934
| -7% | -$138K |
|
550
Virtu Financial
VIRT
$5.2B
| $1.91M | 0.01% |
78,363
+604
| +0.8% | +$15.3K |
|
Similar funds
Mariner's Q3 2021 Portfolio in Review
As of Q3 2021, Mariner held 1,030 positions worth $19.2B, up 19% from $16.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Mariner deployed $3.25B of net new capital in Q3 2021, opening 119 new positions and adding to 631 existing holdings. Its largest new stake was Vanguard Short-Term Treasury ETF: 1,061,938 shares worth $65.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $27.6M trimmed.
- Mariner's largest Q3 2021 buy was Vanguard Short-Term Treasury ETF: 1,061,938 shares worth $65.2M.
- Mariner added most to Vanguard FTSE Developed Markets ETF in Q3 2021, an estimated $312M increase.
- Mariner's biggest Q3 2021 reduction was Intercontinental Exchange, cutting an estimated $27.6M.
- Mariner fully exited Lydall, Inc. in Q3 2021, selling an estimated $2.77M.
- Mariner's ten largest holdings make up 24% of its $19.2B portfolio in Q3 2021.
- Mariner opened 119 new positions and closed 41 in Q3 2021.
- Mariner's portfolio value rose 19% quarter-over-quarter to $19.2B.
Based on Mariner's 13F filing for Q3 2021, filed 15 Nov 2021.